For the first time ever, researchers from the Norwegian University of Science and Technology (NTNU) have identified new ...
A new blended genome genetic test being studied in a major clinical trial may help identify men at highest risk of aggressive prostate cancer and personalise screening strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results